Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angel Lanas

Showing results (171-180 of 270) with videos related to

Pageof 27
Sort By:
Cardiovascular Therapeutics|January 5, 2016
Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI RiskJay L Goldstein, David J Whellan, James M Scheiman, et al.
International Journal of Cardiology. Heart & Vasculature|August 17, 2021
Public health impact of low-dose aspirin on colorectal cancer, cardiovascular disease and safety in the UK - Results from micro-simulation modelJorne Biccler, Kaatje Bollaerts, Pareen Vora, et al.
Human Immunology|August 12, 2009
Relevance of IL-1 and TNF gene polymorphisms on interleukin-1beta and tumor necrosis factor-alpha gastric mucosal productionMaría A García-González, María A Pérez Aísa, Mark Strunk, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|January 14, 2020
Course of the Diverticular Disease: What is changing?Tomica Milosavljeviĉ, Giovanni Brandimarte, Neil Stollman, et al.
Frontiers in Medicine|June 1, 2022
How Donor and Surgical Factors Affect the Viability and Functionality of Human Hepatocytes Isolated From Liver ResectionsEstela Solanas, Nieves Sanchez-Fuentes, Alejandro Serrablo, et al.
Lancet (London, England)|October 17, 2008
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trialJohn A Baron, Robert S Sandler, Robert S Bresalier, et al.
European Cardiology|May 6, 2024
Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysisDirk Sibbing, Michael J Blaha, Rajinder Chawla, et al.
Heart (British Cardiac Society)|March 19, 2011
Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)James M Scheiman, P J Devereaux, Johan Herlitz, et al.
Journal of Cardiovascular Pharmacology|November 29, 2012
Esomeprazole for prevention and resolution of upper gastrointestinal symptoms in patients treated with low-dose acetylsalicylic acid for cardiovascular protection: the OBERON trialJames M Scheiman, Johan Herlitz, Sander J Veldhuyzen van Zanten, et al.
World Journal of Gastroenterology|September 25, 2012
Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in ratsPaula Esquivias, Antonio Morandeira, Alfredo Escartín, et al.
Pageof 27

Showing results (171-180 of 270) with videos related to

Sort By:
Pageof 27
Cardiovascular Therapeutics|January 5, 2016
Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI RiskJay L Goldstein, David J Whellan, James M Scheiman, et al.
International Journal of Cardiology. Heart & Vasculature|August 17, 2021
Public health impact of low-dose aspirin on colorectal cancer, cardiovascular disease and safety in the UK - Results from micro-simulation modelJorne Biccler, Kaatje Bollaerts, Pareen Vora, et al.
Human Immunology|August 12, 2009
Relevance of IL-1 and TNF gene polymorphisms on interleukin-1beta and tumor necrosis factor-alpha gastric mucosal productionMaría A García-González, María A Pérez Aísa, Mark Strunk, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|January 14, 2020
Course of the Diverticular Disease: What is changing?Tomica Milosavljeviĉ, Giovanni Brandimarte, Neil Stollman, et al.
Frontiers in Medicine|June 1, 2022
How Donor and Surgical Factors Affect the Viability and Functionality of Human Hepatocytes Isolated From Liver ResectionsEstela Solanas, Nieves Sanchez-Fuentes, Alejandro Serrablo, et al.
Lancet (London, England)|October 17, 2008
Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trialJohn A Baron, Robert S Sandler, Robert S Bresalier, et al.
European Cardiology|May 6, 2024
Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysisDirk Sibbing, Michael J Blaha, Rajinder Chawla, et al.
Heart (British Cardiac Society)|March 19, 2011
Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)James M Scheiman, P J Devereaux, Johan Herlitz, et al.
Journal of Cardiovascular Pharmacology|November 29, 2012
Esomeprazole for prevention and resolution of upper gastrointestinal symptoms in patients treated with low-dose acetylsalicylic acid for cardiovascular protection: the OBERON trialJames M Scheiman, Johan Herlitz, Sander J Veldhuyzen van Zanten, et al.
World Journal of Gastroenterology|September 25, 2012
Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in ratsPaula Esquivias, Antonio Morandeira, Alfredo Escartín, et al.
Pageof 27